Why the study?
Do long-term anticoagulants (warfarin) reduce the risk of embolic stroke without excessive risk of hemorrhage in patients with nonvalvular atrial fibrillation?
Do long-term anticoagulants (warfarin) reduce the risk of embolic stroke without excessive risk of hemorrhage in patients with nonvalvular atrial fibrillation?
Answers are grounded in this paper and cite their sources.
This article presents a clinical scenario to guide physicians on how to review medical literature regarding anticoagulant use in nonvalvular atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gordon Guyatt (1994) conducted a review in Atrial fibrillation. Warfarin was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: